Predictive value of early and late residual F-fluorodeoxyglucose and F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.

Detalles Bibliográficos
Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 39; no. 7; pp. 1117 - 1128
Autores principales:	Kobe, Carsten, Scheffler, Matthias, Holstein, Arne, Zander, Thomas, Nogova, Lucia, Lammertsma, Adriaan, Boellaard, Ronald, Neumaier, Bernd, Ullrich, Roland, Dietlein, Markus, Wolf, Jürgen, Kahraman, Deniz
Formato:	Journal Article
Publicado:	Springer Nature Jul2012
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Descripción no disponible.